APA aipamena

Cohen, P. R., Tomson, B. N., Elkin, S. K., Marchlik, E., Carter, J. L., & Kurzrock, R. (2016). Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: Implications for targeted therapeutics. Oncotarget.

Chicago Style aipamena

Cohen, Philip R., Brett N. Tomson, Sheryl K. Elkin, Erica Marchlik, Jennifer L. Carter, and Razelle Kurzrock. "Genomic Portfolio of Merkel Cell Carcinoma As Determined By Comprehensive Genomic Profiling: Implications for Targeted Therapeutics." Oncotarget 2016.

MLA aipamena

Cohen, Philip R., et al. "Genomic Portfolio of Merkel Cell Carcinoma As Determined By Comprehensive Genomic Profiling: Implications for Targeted Therapeutics." Oncotarget 2016.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.